Isothermal Nucleic Acid Amplification Technology (INAAT) Market Analysis By Product, By Technology (NASBA, HDA, LAMP, SDA, SPIA, NEAR, TMA, RCA, RPA, SMAP2), And Segment Forecasts, 2014 - 2025

Published: Aug, 2017 | Pages: 150 | Publisher: Grand View Research
Industry: Healthcare | Report Format: Electronic (PDF)

The global isothermal nucleic acid amplification technology (INAAT) market is expected to reach USD 4.3 billion by 2025, growing at a CAGR of 11.8%, according to a new report by Grand View Research, Inc. This can be attributed to significant rise in awareness regarding need for rapid and on-time testing for chronic and infectious diseases. Global increase in adoption of INAAT for detection of HIV, hepatitis A & B, and sexually transmitted diseases is considered to be a high impact rendering driver for growth.

Loop-Mediated Isothermal Amplification is one of the most preferred nucleic acid amplification methods because of its ability to provide point of care testing, thus leading to increased adoption. The recently-introduced Nicking Enzyme Amplification Reaction (NEAR) and Helicase-dependent amplification (HDA) technologies are expected to experience exponential growth during the forecast period owing to their patent protection.

In addition, owing to recent epidemics of infectious diseases, such as tuberculosis, Zika virus, and influenza, importance of point of care diagnosis has increased especially in developing countries. This is also anticipated to boost demand for this technology in these regions.

Further key findings from the report suggest :

• Reagents are expected to be fastest growing products owing to their high usage in all INAAT procedures

• TMA was identified as the largest technology segment by revenue share in 2016 owing to its high adoption

• Infectious disease diagnostics is expected to be the fastest growing application owing to development of numerous assays for detection of specific infectious diseases

• Hospitals dominated the end user segment in 2016 with the largest share and are expected to be continue dominance over the forecast period owing to the high usage of INAAT in hospitals globally

• North America held the largest share of the global market in 2016, and the U.S. held the largest revenue share in the region owing to rise in infectious diseases, availability of government funds, prevalence of cancer, application of MDx in cancer screening & genetic disorders, and self-monitoring techniques

• The molecular diagnostics industry in Asia Pacific is projected to witness substantial growth over the next decade due to various developments in major economies, especially in the NASBA, NEAR, and HDA technology segments

• Some of the key players in the INAAT market include Alere; bioMerieux SA; Eiken Chemical Co. Ltd.; Hologic, Inc. (Gen-Probe); Lucigen; QIAGEN; Quidel Corporation; ThermoFisher Scientific; and Becton, Dickinson & Company

• Major players have been engaging in numerous strategic initiatives such as mergers and acquisitions to increase global presence and improve market share.

 Table of Contents

Chapter 1 Research Methodology & Scope
                 1.1 Information Procurement
                     1.1.1 Purchased database:
                     1.1.2 GVR's internal database
                 1.2 Research Methodology
                 1.3 Geographic scope & assumptions
                 1.4 Region-wise market calculation
                     1.4.1 Region-wise market: Base estimates
                     1.4.2 Global market: CAGR calculation
                 1.5 Region-based segment share calculation
                 1.6 List of Secondary Sources

Chapter 2 Executive Summary
                 2.1 INNAT Market Snapshot

Chapter 3 INNAT Market Variables, Trends & Scope
                 3.1 Market segmentation& scope
                     3.1.1 Market Driver Analysis
                         3.1.1.1 Increasing incidences of chronic diseases and rise in aging population across the globe
                         3.1.1.2 Upsurge in the molecular diagnostics market
                         3.1.1.3 Rise in demand for low cost and effective diagnostics procedures
                         3.1.1.4 Increase in the available disposable income in the developing economies
                         3.1.1.5 Increase in the adoption of INAAT over PCR booming the market growth
                         3.1.1.6 Rise in the miniaturization of nucleic acid based diagnostics
                     3.1.2 Market restraint analysis
                         3.1.2.1 Stringent Regulatory framework
                         3.1.2.2 Threatening opposition from PCR technologies will pose a major challenge
                         3.1.2.3 Lack of awareness over new diagnostics technologies
                 3.2 Penetration & growth prospect mapping
                 3.3 INAAT- SWOT Analysis, By Factor (political & legal, economic and technological)
                 3.4 Industry Analysis - Porter's
                 3.5 POCT (Point-of-Care testing) prompt diagnosis

Chapter 4 INNAT Market: Type of Product Estimates & Trend Analysis
                 4.1 Isothermal nucleic acid amplification market: Type of product movement analysis
                 4.2 Instrument
                     4.2.1 Instrument market, 2014 - 2025 (USD Million)
                 4.3 Reagent
                     4.3.1 Reagent market, 2014 - 2025 (USD Million)

Chapter 5 INNAT Market: Type of Technology Estimates & Trend Analysis
                 5.1 Isothermal nucleic acid amplification market: Type of technology movement analysis
                 5.2 Nucleic acid sequence based amplification (NASBA)
                     5.2.1 Software for primer designing (NASBA)
                     5.2.2 Characteristics and advantages
                     5.2.3 NASBA INAAT market, 2014 - 2025 (USD Million)
                 5.3 Helicase Dependent Amplification (HDA)
                     5.3.1 Characteristics and advantages
                     5.3.2 HDA INAAT market, 2014 - 2025(USD Million)
                 5.4 Loop-mediated isothermal amplification (LAMP)
                     5.4.1 Software for primer designing (LAMP)
                     5.4.2 Characteristics and advantages
                     5.4.3 LAMP INAAT market, 2014 - 2025 (USD Million)
                 5.5 Strand displacement amplification (SDA)
                     5.5.1 Characteristics and advantages
                     5.5.2 SDA INAAT market, 2014 - 2025 (USD Million)
                 5.6 Single primer isothermal amplification (SPIA)
                     5.6.1 Characteristics and advantages
                     5.6.2 SPIA INAAT market, 2014 - 2025 (USD Million)
                 5.7 Nicking enzyme amplification reaction (NEAR)
                     5.7.1 Characteristics and advantages
                     5.7.2 NEAR INAAT market, 2014 - 2025 (USD Million)
                 5.8 Transcription-mediated Amplification (TMA)
                     5.8.1 Characteristics and advantages
                     5.8.2 TMA INAAT market, 2014 - 2025 (USD Million)
                 5.9 Rolling circle amplification (RCP)
                     5.9.1 Characteristics and advantages
                     5.9.2 RCP INAAT market, 2014 - 2025 (USD Million)
                 5.10 Recombinase Polymerase Amplification (RPA)
                     5.10.1 Characteristics and advantages
                     5.10.2 RPA INAAT market, 2014 - 2025 (USD Million)
                 5.11 Smart Amplification Process version 2 (SMAP2)
                     5.11.1 Characteristics and advantages
                     5.11.2 SMAP2 INAAT market, 2014 - 2025 (USD Million)
                 5.12 Others
                     5.12.1 Others market, 2014 - 2025 (USD Million)

Chapter 6 INNAT Market: Type of Application Estimates & Trend Analysis
                 6.1 Isothermal nucleic acid amplification market: Type movement analysis
                 6.2 Blood screening
                     6.2.1 Blood screening market, 2014 - 2025 (USD Million)
                 6.3 Infectious disease diagnostics
                     6.3.1 Infectious disease diagnostic market, 2014 - 2025 (USD Million)
                 6.4 Cancer
                     6.4.1 Cancer market, 2014 - 2025 (USD Million)
                 6.5 Others
                     6.5.1 Others market, 2014 - 2025 (USD Million)

Chapter 7 INNAT Market: Type by End Use Estimates & Trend Analysis
                 7.1 Isothermal nucleic acid amplification market: Application movement analysis
                 7.2 Hospitals
                     7.2.1 Hospitals INAAT market, 2014 - 2025 (USD Million)
                 7.3 Central and reference labs
                     7.3.1 Central and reference labs market, 2014 - 2025 (USD Million)
                 7.4 Others
                     7.4.1 Others market, 2014 - 2025 (USD Million)

Chapter 8 INNAT Market: Regional Estimates & Trend Analysis, by Application
                 8.1 Isothermal nucleic acid amplification market share, by region, 2016 & 2025
                 8.2 North America
                     8.2.1 North America isothermal nucleic acid amplification market, 2014 - 2025(USD Million)
                     8.2.2 U.S
                         8.2.2.1 U.S isothermal nucleic acid amplification market, 2014 - 2025 (USD Million)
                     8.2.3 Canada
                         8.2.3.1 Canada isothermal nucleic acid amplification market, 2014 - 2025 (USD Million)
                 8.3 Europe
                     8.3.1 Europe isothermal nucleic acid amplification market, 2014 - 2025 (USD Million)
                     8.3.2 UK
                         8.3.2.1 UK isothermal nucleic acid amplification market, 2014 - 2025 (USD Million)
                     8.3.3 Germany
                         8.3.3.1 Germany isothermal nucleic acid amplification market, 2014 - 2025 (USD Million)
                 8.4 Asia Pacific
                     8.4.1 Asia Pacific isothermal nucleic acid amplification market , 2014 - 2025 (USD Million)
                     8.4.2 Japan
                         8.4.2.1 Japan isothermal nucleic acid amplification market , 2014 - 2025 (USD Million)
                     8.4.3 China
                         8.4.3.1 China isothermal nucleic acid amplification market, 2014 - 2025 (USD Million)
                     8.4.4 India
                         8.4.4.1 India isothermal nucleic acid amplification market, 2014 - 2025 (USD Million)
                 8.5 Latin America
                     8.5.1 Latin America isothermal nucleic acid amplification market , 2014 - 2025(USD Million)
                     8.5.2 Brazil
                         8.5.2.1 Brazil isothermal nucleic acid amplification market , 2014 - 2025 (USD Million)
                     8.5.3 Mexico
                         8.5.3.1 Mexico isothermal nucleic acid amplification market, 2014 - 2025 (USD Million)
                 8.6 MEA
                     8.6.1 MEA isothermal nucleic acid amplification market, 2014 - 2025 (USD Million)
                     8.6.2 South Africa
                         8.6.2.1 South Africa isothermal nucleic acid amplification market, 2014 - 2025 (USD Million)

Chapter 9 Competitive Landscape
                 9.1 Strategy Framework
                 9.2 Market Participation Categorization
                 9.3 Company Profiles
                     9.3.1 Alere
                         9.3.1.1 Company Overview
                         9.3.1.2 Financial performance
                         9.3.1.3 Product benchmarking
                         9.3.1.4 Strategic initiatives
                     9.3.2 bioMerieux SA
                         9.3.2.1 Company Overview
                         9.3.2.2 Financial performance
                         9.3.2.3 Product benchmarking
                         9.3.2.4 Strategic initiatives
                     9.3.3 Eiken Chemical Co. Ltd
                         9.3.3.1 Company Overview
                         9.3.3.2 Financial performance
                         9.3.3.3 Product benchmarking
                         9.3.3.4 Strategic initiatives
                     9.3.4 Hologic Inc.(Gen-Probe)
                         9.3.4.1 Company Overview
                         9.3.4.2 Financial performance
                         9.3.4.3 Product benchmarking
                         9.3.4.4 Strategic initiatives
                     9.3.5 Lucigen
                         9.3.5.1 Company Overview
                         9.3.5.2 Financial performance
                         9.3.5.3 Product benchmarking
                         9.3.5.4 Strategic initiatives
                     9.3.6 Meridian Bioscience, Inc.
                         9.3.6.1 Company Overview
                         9.3.6.2 Financial performance
                         9.3.6.3 Product benchmarking
                         9.3.6.4 Strategic initiatives
                     9.3.7 Ustar Biotechnologies Ltd.
                         9.3.7.1 Company Overview
                         9.3.7.2 Financial performance
                         9.3.7.3 Product benchmarking
                         9.3.7.4 Strategic initiatives
                     9.3.8 QIAGEN
                         9.3.8.1 Company Overview
                         9.3.8.2 Financial performance
                         9.3.8.3 Product benchmarking
                         9.3.8.4 Strategic initiatives
                     9.3.9 Quidel Corporation
                         9.3.9.1 Company Overview
                         9.3.9.2 Financial performance
                         9.3.9.3 Product benchmarking
                         9.3.9.4 Strategic initiatives
                     9.3.10 Thermo Fisher Scientific Inc.
                         9.3.10.1 Company Overview
                         9.3.10.2 Financial performance
                         9.3.10.3 Product benchmarking
                         9.3.10.4 Strategic initiatives
                     9.3.11 BD (Becton, Dickinson & Company)
                         9.3.11.1 Company Overview
                         9.3.11.2 Financial performance
                         9.3.11.3 Product benchmarking
                         9.3.11.4 Strategic initiatives
                     9.3.12 OptiGene Limited
                         9.3.12.1 Company Overview
                         9.3.12.2 Financial performance
                         9.3.12.3 Product benchmarking
                         9.3.12.4 Strategic initiatives

List of Tables

TABLE 1 Country share estimation
TABLE 2 North America isothermal nucleic acid amplification market estimates and forecasts, by type of synthesis, 2014 - 2025 (USD Million)
TABLE 3 North America isothermal nucleic acid amplification market estimates and forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 4 North America isothermal nucleic acid amplification market estimates and forecasts, by application, 2014 - 2025 (USD Million)
TABLE 5 North America isothermal nucleic acid amplification market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
TABLE 6 U.S. isothermal nucleic acid amplification market estimates and forecasts, by type of synthesis, 2014 - 2025 (USD Million)
TABLE 7 U.S. isothermal nucleic acid amplification market estimates and forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 8 U.S. isothermal nucleic acid amplification market estimates and forecasts, by application, 2014 - 2025 (USD Million)
TABLE 9 U.S. isothermal nucleic acid amplification market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
TABLE 10 Canada isothermal nucleic acid amplification market estimates and forecasts, by type of synthesis, 2014 - 2025 (USD Million)
TABLE 11 Canada isothermal nucleic acid amplification market estimates and forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 12 Canada isothermal nucleic acid amplification market estimates and forecasts, by application, 2014 - 2025 (USD Million)
TABLE 13 Canada isothermal nucleic acid amplification market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
TABLE 14 Europe isothermal nucleic acid amplification market estimates and forecasts, by type of synthesis, 2014 - 2025 (USD Million)
TABLE 15 Europe isothermal nucleic acid amplification market estimates and forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 16 Europe isothermal nucleic acid amplification market estimates and forecasts, by application, 2014 - 2025 (USD Million)
TABLE 17 Europe isothermal nucleic acid amplification market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
TABLE 18 UK isothermal nucleic acid amplification market estimates and forecasts, by type of synthesis, 2014 - 2025 (USD Million)
TABLE 19 UK isothermal nucleic acid amplification market estimates and forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 20 UK isothermal nucleic acid amplification market estimates and forecasts, by application, 2014 - 2025 (USD Million)
TABLE 21 UK isothermal nucleic acid amplification market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
TABLE 22 Germany isothermal nucleic acid amplification market estimates and forecasts, by type of synthesis, 2014 - 2025 (USD Million)
TABLE 23 Germany isothermal nucleic acid amplification market estimates and forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 24 Germany isothermal nucleic acid amplification market estimates and forecasts, by application, 2014 - 2025 (USD Million)
TABLE 25 Germany isothermal nucleic acid amplification market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
TABLE 26 Asia Pacific isothermal nucleic acid amplification market estimates and forecasts, by type of synthesis, 2014 - 2025 (USD Million)
TABLE 27 Asia Pacific isothermal nucleic acid amplification market estimates and forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 28 Asia Pacific isothermal nucleic acid amplification market estimates and forecasts, by application, 2014 - 2025 (USD Million)
TABLE 29 Asia Pacific isothermal nucleic acid amplification market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
TABLE 30 Japan isothermal nucleic acid amplification market estimates and forecasts, by type of synthesis, 2014 - 2025 (USD Million)
TABLE 31 Japan isothermal nucleic acid amplification market estimates and forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 32 Japan isothermal nucleic acid amplification market estimates and forecasts, by application, 2014 - 2025 (USD Million)
TABLE 33 Japan isothermal nucleic acid amplification market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
TABLE 34 China isothermal nucleic acid amplification market estimates and forecasts, by type of synthesis, 2014 - 2025 (USD Million)
TABLE 35 China isothermal nucleic acid amplification market estimates and forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 36 China isothermal nucleic acid amplification market estimates and forecasts, by application, 2014 - 2025 (USD Million)
TABLE 37 China isothermal nucleic acid amplification market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
TABLE 38 India isothermal nucleic acid amplification market estimates and forecasts, by type of synthesis, 2014 - 2025 (USD Million)
TABLE 39 India isothermal nucleic acid amplification market estimates and forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 40 India isothermal nucleic acid amplification market estimates and forecasts, by application, 2014 - 2025 (USD Million)
TABLE 41 India isothermal nucleic acid amplification market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
TABLE 42 Latin America isothermal nucleic acid amplification market estimates and forecasts, by type of synthesis, 2014 - 2025 (USD Million)
TABLE 43 Latin America isothermal nucleic acid amplification market estimates and forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 44 Latin America isothermal nucleic acid amplification market estimates and forecasts, by application, 2014 - 2025 (USD Million)
TABLE 45 Latin America isothermal nucleic acid amplification market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
TABLE 46 Brazil isothermal nucleic acid amplification market estimates and forecasts, by type of synthesis, 2014 - 2025 (USD Million)
TABLE 47 Brazil isothermal nucleic acid amplification market estimates and forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 48 Brazil isothermal nucleic acid amplification market estimates and forecasts, by application, 2014 - 2025 (USD Million)
TABLE 49 Brazil isothermal nucleic acid amplification market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
TABLE 50 Mexico isothermal nucleic acid amplification market estimates and forecasts, by type of synthesis, 2014 - 2025 (USD Million)
TABLE 51 Mexico isothermal nucleic acid amplification market estimates and forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 52 Mexico isothermal nucleic acid amplification market estimates and forecasts, by application, 2014 - 2025 (USD Million)
TABLE 53 Mexico isothermal nucleic acid amplification market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
TABLE 54 MEA isothermal nucleic acid amplification market estimates and forecasts, by type of synthesis, 2014 - 2025 (USD Million)
TABLE 55 MEA isothermal nucleic acid amplification market estimates and forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 56 MEA isothermal nucleic acid amplification market estimates and forecasts, by application, 2014 - 2025 (USD Million)
TABLE 57 MEA isothermal nucleic acid amplification market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
TABLE 58 South Africa isothermal nucleic acid amplification market estimates and forecasts, by type of synthesis, 2014 - 2025 (USD Million)
TABLE 59 South Africa isothermal nucleic acid amplification market estimates and forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 60 South Africa isothermal nucleic acid amplification market estimates and forecasts, by application, 2014 - 2025 (USD Million)
TABLE 61 South Africa isothermal nucleic acid amplification market estimates and forecasts, by end use, 2014 - 2025 (USD Million)